| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.01.24 | Optinose, Inc.: Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice | 126 | GlobeNewswire (Europe) | XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and... ► Artikel lesen | |
| 18.01.24 | OrderYOYO A/S: OrderYOYO publishes ARR, Net Revenue and EBITDA significantly above latest guidance. 2024 guidance significantly raised | 187 | GlobeNewswire (Europe) | Company Announcement No. 69 - 2024
OrderYOYO A/S
Inside InformationCopenhagen, January 18, 2024
Highlights
Business continues to perform strongly and above guidance. Highly focused strategy... ► Artikel lesen | |
| 18.01.24 | Etteplan Oyj: Etteplan issues a profit warning: according to the preliminary result, Etteplan's revenue for 2023 is about EUR 359 million and the operating profit (EBIT) is about EUR 25.4 million | 155 | GlobeNewswire (Europe) | Etteplan Oyj, Stock Exchange Release/Insider information, January 18, 2024 at 8 a.m. EET
Etteplan issues a profit warning
According to the preliminary result, Etteplan's revenue for 2023 is about... ► Artikel lesen | |
| 18.01.24 | Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination | 233 | GlobeNewswire (Europe) | WEST HOLLYWOOD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. ("Bannix") announced today that its board of directors (the "Board") has decided to extend the date by which Bannix... ► Artikel lesen | |
| 18.01.24 | Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap | 278 | GlobeNewswire (Europe) | REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve... ► Artikel lesen | |
| 18.01.24 | GH Research PLC: GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression | 245 | GlobeNewswire (Europe) | DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological... ► Artikel lesen | |
| 18.01.24 | Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024 | 236 | GlobeNewswire (Europe) | NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. ("Aimei") announced today that, commencing January 22, 2024, holders of the units sold in the Company's initial public... ► Artikel lesen | |
| 18.01.24 | Arisz Acquisition Corp. Announces Extension of Deadline to Complete Business Combination | 123 | GlobeNewswire (Europe) | New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Arisz Acquisition Corp. (NASDAQ: ARIZ ("Arisz" or the "Company"), a special purpose acquisition company, announced today that Arisz Investments LLC... ► Artikel lesen | |
| 18.01.24 | Mesa Air Group, Inc.: Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program | 376 | GlobeNewswire (Europe) | PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced agreements with United Airlines ("United") to amend its capacity purchase agreement... ► Artikel lesen | |
| 18.01.24 | OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results | 2.036 | GlobeNewswire (Europe) | RED BANK, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:"OCFC") (the "Company"), the holding company for OceanFirst Bank N.A. (the "Bank"), announced net income available... ► Artikel lesen | |
| 18.01.24 | Bioventus, Inc.: Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility | 369 | GlobeNewswire (Europe) | DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today announced that it has entered... ► Artikel lesen | |
| 18.01.24 | Bird Construction Inc: Bird Bolsters Capabilities, Capacity, and Recurring Revenue With Agreement to Acquire Leading Alberta Electrical Service Provider | 309 | GlobeNewswire (Europe) | MISSISSAUGA, Ontario, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) announced today that it has acquired the assets of NorCan Electric Inc. ("NorCan") for a total consideration... ► Artikel lesen | |
| 18.01.24 | GitLab Inc.: GitLab Appoints Sabrina Farmer as Chief Technology Officer | 625 | GlobeNewswire (Europe) | SAN FRANCISCO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- All Remote - GitLab Inc., the most comprehensive AI-powered DevSecOps platform, today announced the appointment of Sabrina Farmer as its chief technology... ► Artikel lesen | |
| 18.01.24 | SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable | 510 | GlobeNewswire (Europe) | Davos, Switzerland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology... ► Artikel lesen | |
| 18.01.24 | Phaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024 | 511 | GlobeNewswire (Europe) | Lyon (France) and Cambridge (MA, US), January 18, 2024, at 10:05pm CET - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and... ► Artikel lesen | |
| 18.01.24 | QIAGEN N.V.: QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million | 499 | GlobeNewswire (Europe) | Venlo, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return... ► Artikel lesen | |
| 18.01.24 | NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders | 356 | GlobeNewswire (Europe) | BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines... ► Artikel lesen | |
| 18.01.24 | Ikena Oncology, Inc.: Ikena Oncology Outlines Key Priorities and Provides Corporate Updates | 434 | GlobeNewswire (Europe) | IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort treated and cleared safety evaluation window Focused execution on core... ► Artikel lesen | |
| 18.01.24 | Bank OZK Announces Record Fourth Quarter and Full Year 2023 Earnings | 422 | GlobeNewswire (Europe) | LITTLE ROCK, Ark., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bank OZK (the "Bank") (Nasdaq: OZK) today announced that net income available to common stockholders for the fourth quarter of 2023 was a record... ► Artikel lesen | |
| 18.01.24 | PMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway | 385 | GlobeNewswire (Europe) | Prioritization of PC14586 development and focused discovery research efforts results in a workforce reduction of approximately 30%Unaudited cash, cash equivalents, and marketable securities totaling... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 601 |
| EVOTEC | 334 |
| NOVO NORDISK | 323 |
| TESLA | 291 |
| RHEINMETALL | 246 |
| BYD | 233 |
| RENK GROUP | 170 |
| DEUTZ | 162 |
| TUI | 135 |
| APPLE | 132 |
| BASF | 132 |
| VOLKSWAGEN | 130 |
| STEYR MOTORS | 128 |
| NETFLIX | 127 |
| BAYER | 126 |
| PLUG POWER | 122 |
| AMAZON | 117 |
| UNITEDHEALTH | 114 |
| ALMONTY | 113 |
| XIAOMI | 108 |
| COMMERZBANK | 107 |
| E.ON | 105 |
| NEL | 105 |
| RWE | 105 |
| SIEMENS ENERGY | 100 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
